COVID-19 Project Topics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
* [[Nephrologic Disorders and COVID-19]] | * [[Nephrologic Disorders and COVID-19]] | ||
* [[Neurologic Disorders and COVID-19]] | * [[Neurologic Disorders and COVID-19]] | ||
* Ongoing Clinical Trials of COVID-19 | * [[COVID-19 future or investigational therapies|Ongoing Clinical Trials of COVID-19]] | ||
* [[Pulmonary Disorders and COVID-19]] | * [[Pulmonary Disorders and COVID-19]] | ||
*[[Pediatrics and COVID-19]] | *[[Pediatrics and COVID-19]] | ||
*[[Gastrointestinal disorders and of COVID-19]] | *[[Gastrointestinal disorders and of COVID-19]] | ||
Revision as of 15:43, 12 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
List of All Topics
COVID-19 Organ-Based Complications
- Cardiovascular Disorders and COVID-19
- Dermatologic Disorders of COVID-19
- Hematologic disorders and COVID-19
- Nephrologic Disorders and COVID-19
- Neurologic Disorders and COVID-19
- Ongoing Clinical Trials of COVID-19
- Pulmonary Disorders and COVID-19
- Pediatrics and COVID-19
- Gastrointestinal disorders and of COVID-19